Clinical Trial Update: Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Kyowa Kirin announced a Phase 1 clinical trial evaluating KK2845 in relapsed or refractory acute myeloid leukemia, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory Acute Myeloid Leukemia

Drugs mentioned

• KK2845

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Relapsed or Refractory Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING